Biofourmis

Biofourmis wishes you and your loved ones a safe and happy Independence Day! 🎇 I #IndependenceDay #FourthOfJuly #LifeAtBiofourmis #BostonBased

"Wearable sensor technologies are revolutionizing health research, especially in chronic disease management, by producing real-time health data that can be transformed into digital biomarkers." However, systematic methods for collecting, interpreting, analyzing, and translating this data are lacking. Drawing from the BarKA-MS observational, longitudinal cohort study on physical rehabilitation in individuals with multiple sclerosis (MS), new research presents ten key insights into digital biomarker development. These lessons are intended to guide future research and teaching in utilizing wearable sensor data for digital biomarker development and chronic disease management. https://lnkd.in/gfGhr4J5 I #ChronicDiseaseManagement #DigitalBiomarkers #DigitalHealth Nature Portfolio

Virtual care has proven to be an effective tool, yielding high patient satisfaction without adverse safety events, according to a study published in JAMA Network Open. Focused on remote radiation oncology care, the study revealed that patients rated virtual care as good or very good, with nearly all avoiding adverse safety events. The remote model significantly reduced travel burdens and costs for patients, with substantial mileage and cost savings reported. Among nearly 3,000 patients surveyed from 2020 to 2022, 98% expressed high satisfaction, and most safety events posed no harm to patients. Researchers emphasized the benefits of remote care, including enhanced access to clinicians, reduced travel, and significant cost savings. These findings suggest that virtual care will continue to play a vital role in chronic care management. https://lnkd.in/grMkeqTZ I #Oncology #RemotePatientMonitoring 

Despite pharma’s emphasis on diversity in clinical trials, many are failing to meet these goals. A recent report from the Office of Inspector General, which reviewed 30 phase 3 trials funded by The National Institutes of Health, revealed that only two-thirds had inclusive enrollment plans. Even among those with such plans, most did not achieve their targets for underrepresented groups. To extend trial participation, many are looking towards scalable, comprehensive decentralized clinical trial solutions that enhance participant engagement and alleviate site burden. By building patient-centric diversified clinical trials, pharma can ensure more representative data, improve the efficacy and safety of treatments across different populations, and ultimately enhance health outcomes for all patients. https://lnkd.in/g-e4gGvM I #DecentralizedClinicalTrials #ClinicalTrialDiversity #DigitalClinicalTrials #HealthEquity PharmaVoice

Digital Health Technologies (DHTs) are increasingly contributing to the economic affordability and environmental sustainability of healthcare systems. By offering customized, adaptable care solutions, they have the potential to facilitate safer and more extensive home-based care while empowering patients to actively engage in their health management. However, substantial national differences exist in how these technologies are perceived, evaluated for regulatory approval, and reimbursed. Researchers are exploring the emerging phenomenon of grouping individual DHTs—each with its own clinical use case and regulatory approval—into packages designed to perform specific clinical tasks in defined settings. https://lnkd.in/ech-f7Hp I #DigitalHealth #RemotePatientMonitoring #VirtualCare #HealthcareInnovation

A new survey from EY’s suggests that digital health technologies are starting to yield strong results for payers. Ernst & Young LLP announced the results of a survey it conducted amongst health insurance executives, revealing that nearly four out of five insurance leaders acknowledge that virtual care has not only bridged the distance between members and providers but has also made care more affordable for members. https://lnkd.in/dx_rWqnC I #DigitalHealth #HealthcareCosts #VirtualCare

Hospitals face inpatient bed capacity constraints from extended stays, staffing shortages and overcrowding. In partnership with Biofourmis, this Becker's Healthcare white paper examines how care-at-home solutions alleviate strain by facilitating early discharges, transitional care, chronic disease management and resource optimization. Download now to: 🛌 Uncover the underlying challenges that are leading to constrained inpatient bed capacity 🏥 Understand how innovative care-at-home solutions can help unlock hospital capacity 🏡 Discover insights from leading health systems about successful care-at-home programs https://lnkd.in/gZiDutHa I #HospitalAtHome #HospitalBedCapacity #ChronicDiseaseManagement #RemotePatientMonitoring

Remote patient monitoring (RPM) can improve clinical outcomes by extending care beyond hospitals, but its growth is hindered by low reimbursement. A report by the Bipartisan Policy Center outlines strategies to address this issue, including collaborating with medical societies to determine optimal coverage, clarifying policies, and developing new billing codes. It also suggests that Congress request the Medicare Payment Advisory Commission (MedPAC) evaluate RPM’s impact on clinical outcomes and costs. These recommendations aim to advance RPM, particularly for smaller hospitals and underserved populations with limited resources. https://bit.ly/4emlD80 I #RemotePatientMonitoring #VirtualCare #CareAtHome #DigitalHealth HealthLeaders

Biofourmis Chief Operating Officer Jaydev Thakkar will be in Basel, Switzerland on June 26 for the 7th annual Digital Biomarkers in Clinical Trials Summit to participate in a panel discussion on digital biomarkers in Oncology. Thakkar will join leaders from Roche, Johnson & Johnson Innovative Medicine, and Evinova to go beyond the more established field of measuring activity levels and motor symptoms with digital health tools, to discuss what additional measurement approaches are being explored within Oncology. Heading to Basel? Send us a message! We’d love to share more about how our pharma partners are leveraging our enterprise platform and device ecosystem to advance cancer research and development. https://lnkd.in/drySvksT I #DigitalBiomarkers #Oncology #DigitalClinicalTrials #ClinicalTrials #DigitalHealth

Health systems like Wellstar MCG Health are leveraging Biofourmis’ remote patient management technology to level up their virtual care capabilities.   In an interview with mHealthIntelligence’s Anuja Vaidya, Lauren Williams Hopkins, MPH, assistant vice president of virtual care and community engagement at Wellstar MCG Health, details the health system’s evolving goals for their Virtual Care at Home program. Hopkins noted that selecting a new technology vendor with a scalable platform to support a growing patient volume and condition mix became critical to growing the program. With the help of Biofourmis, the health system has improved throughput in the emergency department and inpatient setting, reducing hospital readmissions, enabling optimal clinical outcomes, and improving the experience of patients and their families.   https://lnkd.in/g2SHyHUd I #RemotePatientMonitoring #HospitalAtHome #DigitalHealth #VirtualCare #ChronicDiseaseManagement #CareAtHome